Whether Vigabatrin (Ocoda) is a prohibited drug and related regulations

Vigabatrin is a gamma-aminobutyric acid (GABA) analogue, mainly used to treat refractory epilepsy and infantile spasms (West syndrome) and other diseases. From the perspective of drug properties, Vigabatrin is a legal prescription drug, not an illegal drug. Its original intention and main use are in the field of neurology, and it can control epileptic seizures by enhancing the effect of inhibitory neurotransmitters. Therefore, Vigabatrin is widely recognized as a formal anti-epileptic drug around the world, including Europe, the United States and some Asian countries.

From the perspective of drug control, Vigabatrin does not belong to narcotic drugs, psychotropic drugs or narcotic controlled substances, so it will not be included in the scope of "prohibited drugs". However, it should be noted that because Vigabatrin may cause severe retinal damage and vision defects, some countries or regions have strict restrictions on its use. For example, in the United States, Vigabatrin is managed through the Risk Evaluation and Mitigation Strategy (REMS) program, and doctors and pharmacies need to be specially registered before they can prescribe and dispense the drug. This is also to reduce the risk of patients suffering from irreversible vision damage due to long-term use.

At the domestic regulatory level, Vigabatrin is not included in the "Management Catalog of Narcotic Drugs and Psychotropic Drugs" and has not been recognized as a prohibited drug. However, it falls under the management of imported drugs and can only be legally sold and used through formal channels approved by the National Medical Products Administration (NMPA). If patients purchase drugs through informal channels, there will be unknown drug quality, unknown sources, and legal risks. Therefore, if domestic patients need to use Vigabatrin, they should strictly follow the doctor’s prescription and obtain it through regular hospitals or legal import channels.
Overall, Vigabatrin is not an illegal drug but is a legal prescription anti-epileptic drug. However, due to its specific risk of adverse reactions, relevant regulations have imposed additional restrictions on its use and access channels. Patients should follow the doctor's guidance during use, undergo regular vision examinations, and avoid purchasing drugs through illegal channels. For parents, if their child is recommended to use Vigabatrin due to epilepsy or infantile spasms, they should understand the relevant medication risks and regulatory requirements to ensure that the medication is safe and legal.
Reference link: https://www.drugs.com